Literature DB >> 33459176

Molecular docking and simulation studies of natural compounds of Vitex negundo L. against papain-like protease (PLpro) of SARS CoV-2 (coronavirus) to conquer the pandemic situation in the world.

Debasis Mitra1, Devvret Verma2, Bhaswatimayee Mahakur3, Anshul Kamboj2, Rakesh Srivastava4, Sugam Gupta5, Ajita Pandey6, Bhawna Arora7, Kumud Pant2, P Panneerselvam8, Arabinda Ghosh9, Durga P Barik3, Pradeep K Das Mohapatra1.   

Abstract

The severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) is β-coronavirus that is responsible for the pandemic coronavirus disease 2019 (COVID-19) all over the world. The rapid spread of the novel SARS CoV-2 worldwide is raising a significant global public health issue with nearly 61.86 million people infected and 1.4 million deaths. To date, no specific drugs are available for the treatment of COVID-19. The inhibition of proteases essential for the proteolytic treatment of viral polyproteins is a conventional therapeutic strategy for conquering viral infections. In the study, molecular docking approach was used to screen potential drug compounds among the phytochemicals of Vitex negundo L. against COVID-19 infection. Molecular docking analysis showed that oleanolic acid forms a stable complex and other phyto-compounds ursolic acid, 3β-acetoxyolean-12-en-27-oic acid and isovitexin of V. negundo natural compounds form a less-stable complex. When compared with the control the synergistic interaction of these compounds shows inhibitory activity against papain-like protease (PLpro) of SARS CoV-2 (COVID-19). The molecular dynamics (MD) simulation (50 ns) were performed on the complexes of PLpro and the phyto-compounds viz. oleanolic acid, ursolic acid, 3β-acetoxyolean-12-en-27-oic acid and isovitexin followed by the binding free energy calculations using MM-GBSA and these molecules have stable interactions with PLpro protein binding site. The MD simulation study provides more insight into the functional properties of the protein-ligand complex and suggests that these molecules can be considered as a potential drug molecule against COVID-19. In this pandemic situation, these herbal compounds provide a rich resource to produce new antivirals against COVID-19.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  PLpro; SARS CoV-2; Vitex negundo; compounds; molecular dynamics

Mesh:

Substances:

Year:  2021        PMID: 33459176     DOI: 10.1080/07391102.2021.1873185

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102            Impact factor:   5.235


  7 in total

Review 1.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Limei Cheng; Jaclyn Frishcosy; Yuta Huzumi; Yuchi Qiu; Tom Schluckbier; Xiaoqi Wei; Guo-Wei Wei
Journal:  Chem Rev       Date:  2022-05-20       Impact factor: 72.087

2.  Point-specific interactions of isovitexin with the neighboring amino acid residues of the hACE2 receptor as a targeted therapeutic agent in suppressing the SARS-CoV-2 influx mechanism.

Authors:  Nourin Ferdausi; Samarth Islam; Fahmida Hoque Rimti; Syeda Tasnim Quayum; Efat Muhammad Arshad; Aashian Ibnat; Tamnia Islam; Adittya Arefin; Tanzila Ismail Ema; Partha Biswas; Dipta Dey; Salauddin Al Azad
Journal:  J Adv Vet Anim Res       Date:  2022-06-26

3.  Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach.

Authors:  Anuj Kumar; Mansi Sharma; Christopher D Richardson; David J Kelvin
Journal:  Front Mol Biosci       Date:  2022-05-10

4.  In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides.

Authors:  Mohammad Moradi; Reza Golmohammadi; Ali Najafi; Mehrdad Moosazadeh Moghaddam; Mahdi Fasihi-Ramandi; Reza Mirnejad
Journal:  Int J Pept Res Ther       Date:  2021-12-09       Impact factor: 1.931

Review 5.  Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2.

Authors:  B Uma Reddy; Nanda Kishore Routhu; Anuj Kumar
Journal:  Microb Pathog       Date:  2022-04-02       Impact factor: 3.848

6.  Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study.

Authors:  Ajita Pandey; Mohit Sharma
Journal:  Future Virol       Date:  2021-07-13       Impact factor: 1.831

Review 7.  Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights.

Authors:  Sabeeha Ali; Manzar Alam; Fatima Khatoon; Urooj Fatima; Abdelbaset Mohamed Elasbali; Mohd Adnan; Asimul Islam; Md Imtaiyaz Hassan; Mejdi Snoussi; Vincenzo De Feo
Journal:  Biomed Pharmacother       Date:  2022-01-20       Impact factor: 6.529

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.